3.48 USD
↘ 0.08 (2.11%)LIVE (AS OF 02:47 PM EDT)
Rocket Pharmaceuticals, Inc. Common Stock
RCKTNASDAQ • USD
Market: OPEN
Open?$3.48
High?$3.69
Low?$3.47
Prev. Close?$3.55
Volume?1.8M
Avg. Volume?4.7M
VWAP?$3.53
Rel. Volume?0.38x
Bid / Ask
Bid?$3.47 × 2.3K
Ask?$3.48 × 1.1K
Spread?$0.01
Midpoint?$3.48
Valuation & Ratios
Market Cap?385.4M
Shares Out?109.1M
Float?82.2M
Float %?75.9%
P/E Ratio?N/A
P/B Ratio?1.39
EPS?-$2.06
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.38Strong
Quick Ratio?6.38Strong
Cash Ratio?2.57Strong
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.39CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-80.5%WEAK▾
ROA?-67.5%WEAK▾
Cash Flow & Enterprise
FCF?$-190454000
Enterprise Value?$329.1M
Related Companies
Loading...
News
Profile
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Employees
202
Market Cap
385.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-02-18
Address
350 FIFTH AVENUE
NEW YORK, NY 10118
Phone: 646-440-9100
NEW YORK, NY 10118
Phone: 646-440-9100